Montreal, Canada, May 25, 2020 – Apotex, Canada’s largest pharmaceutical manufacturer donated thousands of bottles of hand sanitizer across ten hospitals in Montreal and surrounding areas to help protect frontline workers and patients in the fight against COVID-19.
“With the largest part of our global operations in Canada, we are always focused on supporting the communities in which we live and work” said Ray Shelley, SVP, Commercial Operations-Canada & Caribbean, Apotex. “We recognize that the number of COVID-19 cases remains high in Quebec, and we are pleased to step up and support the province’s frontline workers and patients in hospitals with much-needed hand sanitizer.”
Since April 2020, Apotex Pharmachem, a division of Apotex and Canada’s largest producer of active pharmaceutical ingredients, has been using its Health-Canada approved technical expertise and manufacturing capability to produce hand sanitizer to be distributed among healthcare facilities and communities in Canada.
The pandemic has highlighted that now more than ever, domestic manufacturing is essential as it enables agility and flexibility in manufacturing capabilities based on patient, industry and community needs.
This announcement builds on Apotex’s commitment of donating two million dosages of Hydroxychloroquine to the Public Health Agency of Canada for use in clinical trials being conducted within Canada, including multiple studies being conducted at clinical sites in Quebec that will impact Quebec patients.
To learn more about Apotex’s ongoing efforts in response to COVID-19, please visit: https://www.apotex.com/global/covid-19-update
About Apotex Inc.
Apotex Inc. is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines for patients around the world. Apotex employs almost 8,000 people worldwide in manufacturing, R&D, and commercial operations. Apotex Inc. exports to more than 100 countries and territories and operates in more than 45 countries, with a significant presence in Canada, the US, Mexico, and India. Through vertical integration, Apotex is comprised of multiple divisions and affiliates including Apotex Inc., focused on generics; Apobiologix, a division of Apotex Inc. focused on biosimilar development; Aveva, an affiliate of Apotex Inc. fully integrated global developer and manufacturer of complete transdermal solutions; Apotex Consumer Products, a division of Apotex Inc. focused on brand name products; and Global Active Pharmaceutical Ingredients (GAPI), a division of Apotex Inc. focused on the manufacturing of active pharmaceutical ingredients (API) for Apotex and third parties. For more information visit: www.apotex.com.
All media inquiries:
Vice-President, Global Corporate Affairs